Pneumatosis intestinalis after gefitinib therapy for pulmonary adenocarcinoma: a case report
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-7819
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Pneumatosis intestinalis after gefitinib therapy for pulmonary adenocarcinoma: a case report ; volume:14 ; number:1 ; day:29 ; month:6 ; year:2016 ; pages:1-4 ; date:12.2016
World journal of surgical oncology ; 14, Heft 1 (29.6.2016), 1-4, 12.2016
- Urheber
-
Maeda, Ai
- Beteiligte Personen und Organisationen
-
Nakata, Masao
Shimizu, Katsuhiko
Yukawa, Takuro
Saisho, Shinsuke
Okita, Riki
SpringerLink (Online service)
- DOI
-
10.1186/s12957-016-0926-1
- URN
-
urn:nbn:de:1111-201609023690
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:44 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Maeda, Ai
- Nakata, Masao
- Shimizu, Katsuhiko
- Yukawa, Takuro
- Saisho, Shinsuke
- Okita, Riki
- SpringerLink (Online service)
Ähnliche Objekte (12)
Pneumatosis intestinalis and portal venous gas secondary to Gefitinib therapy for lung adenocarcinoma
Orbital metastasis secondary to pulmonary adenocarcinoma treated with gefitinib: a case report
Gefitinib-induced skin ulceration in metastatic adenocarcinoma lung
Gefitinib successfully administered in a lung cancer patient with leptomeningeal carcinomatosis after erlotinib-induced pneumatosis intestinalis
CA916798 predicts poor prognosis and promotes Gefitinib resistance for lung adenocarcinoma
Pneumatosis intestinalis
Ulva intestinalis
Ulva intestinalis
Lamblia intestinalis
Lack of EGFR mutations benefiting gefitinib treatment in adenocarcinoma of esophagogastric junction
IV. Lumbricus, intestinalis.
Pulmonary invasive mucinous adenocarcinoma mimicking pulmonary actinomycosis
Pneumatosis intestinalis and portal venous gas secondary to Gefitinib therapy for lung adenocarcinoma
Orbital metastasis secondary to pulmonary adenocarcinoma treated with gefitinib: a case report
Gefitinib-induced skin ulceration in metastatic adenocarcinoma lung
Gefitinib successfully administered in a lung cancer patient with leptomeningeal carcinomatosis after erlotinib-induced pneumatosis intestinalis
CA916798 predicts poor prognosis and promotes Gefitinib resistance for lung adenocarcinoma
Pneumatosis intestinalis
Ulva intestinalis
Ulva intestinalis
Lamblia intestinalis
Lack of EGFR mutations benefiting gefitinib treatment in adenocarcinoma of esophagogastric junction
IV. Lumbricus, intestinalis.
Pulmonary invasive mucinous adenocarcinoma mimicking pulmonary actinomycosis
Pneumatosis intestinalis and portal venous gas secondary to Gefitinib therapy for lung adenocarcinoma
Orbital metastasis secondary to pulmonary adenocarcinoma treated with gefitinib: a case report
Gefitinib-induced skin ulceration in metastatic adenocarcinoma lung
Gefitinib successfully administered in a lung cancer patient with leptomeningeal carcinomatosis after erlotinib-induced pneumatosis intestinalis
CA916798 predicts poor prognosis and promotes Gefitinib resistance for lung adenocarcinoma
Pneumatosis intestinalis
Ulva intestinalis
Ulva intestinalis
Lamblia intestinalis
Lack of EGFR mutations benefiting gefitinib treatment in adenocarcinoma of esophagogastric junction
IV. Lumbricus, intestinalis.